These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21898662)

  • 1. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
    Nasim MT; Ogo T; Ahmed M; Randall R; Chowdhury HM; Snape KM; Bradshaw TY; Southgate L; Lee GJ; Jackson I; Lord GM; Gibbs JS; Wilkins MR; Ohta-Ogo K; Nakamura K; Girerd B; Coulet F; Soubrier F; Humbert M; Morrell NW; Trembath RC; Machado RD
    Hum Mutat; 2011 Dec; 32(12):1385-9. PubMed ID: 21898662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
    Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
    Morty RE; Nejman B; Kwapiszewska G; Hecker M; Zakrzewicz A; Kouri FM; Peters DM; Dumitrascu R; Seeger W; Knaus P; Schermuly RT; Eickelberg O
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1072-8. PubMed ID: 17347486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.
    Shintani M; Yagi H; Nakayama T; Saji T; Matsuoka R
    J Med Genet; 2009 May; 46(5):331-7. PubMed ID: 19211612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.
    Tsukamoto S; Mizuta T; Fujimoto M; Ohte S; Osawa K; Miyamoto A; Yoneyama K; Murata E; Machiya A; Jimi E; Kokabu S; Katagiri T
    Sci Rep; 2014 Dec; 4():7596. PubMed ID: 25534700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Biomarkers for Schistosoma-Associated Pulmonary Arterial Hypertension Based on RNA-Seq Data of Mouse Whole Lung Tissues.
    Sun Y; Lin X; Li L
    Lung; 2017 Jun; 195(3):377-385. PubMed ID: 28393260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.
    Machado RD; Southgate L; Eichstaedt CA; Aldred MA; Austin ED; Best DH; Chung WK; Benjamin N; Elliott CG; Eyries M; Fischer C; Gräf S; Hinderhofer K; Humbert M; Keiles SB; Loyd JE; Morrell NW; Newman JH; Soubrier F; Trembath RC; Viales RR; Grünig E
    Hum Mutat; 2015 Dec; 36(12):1113-27. PubMed ID: 26387786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counselling in a national referral centre for pulmonary hypertension.
    Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
    Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension.
    Chida A; Shintani M; Nakayama T; Furutani Y; Hayama E; Inai K; Saji T; Nonoyama S; Nakanishi T
    Circ J; 2012; 76(6):1501-8. PubMed ID: 22374147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension.
    Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP
    Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of pulmonary arterial hypertension.
    Elliott CG
    Clin Chest Med; 2013 Dec; 34(4):651-63. PubMed ID: 24267296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9).
    Yuan H; Sehgal PB
    PLoS One; 2016; 11(11):e0166382. PubMed ID: 27875556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.